Vietnam Official Urges Drug Industry To Plan For Local Market Control
This article was originally published in PharmAsia News
Executive Summary
Vietnam's deputy prime minister has appealed to the nation's drug and chemical industries to develop a program that would lead to domestic control over the local pharmaceutical market by 2020. Hoang Trung Hai appealed to Vietnam Pharmaceutical Corp. and Vietnam National Chemical Corp. to work out a project that would allow government agencies to develop the policies necessary for that goal. He also called for an increase in research and stepped-up development of industry infrastructure, particularly their technology and equipment, 60 percent of which is imported. (Click here for more
You may also be interested in...
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.